Department of Psychiatry and Institute of Medical Science, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Department of Psychiatry and Institute of Medical Science, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Med Hypotheses. 2018 Jun;115:94-102. doi: 10.1016/j.mehy.2018.04.005. Epub 2018 Apr 11.
Lithium is a medication used to treat bipolar disorder and may also prevent cognitive decline and suicide. Lithium is also found naturally, in levels well below clinical doses, in drinking water worldwide, and levels have been inversely associated with rates of psychiatric disorders. Lead (Pb) is another element in the environment but is a toxin of public health concern. Negative effects of chronic lead exposure and possible benefits of environmental lithium exposure appear complementary.
Exposure to environmental lithium has associated benefits, which may be due to the mitigation of lead toxicity by lithium.
A series of reviews tested each element of the hypothesis. A systematic review clarified the psychiatric and medical correlates of lithium in drinking water. Non-systematic reviews clarified the harms of environmental lead, summarized experimental studies of lithium used to prevent lead toxicity, and explored overlapping biological mechanisms in lithium and lead exposure.
Higher levels of lithium in drinking water were associated with lower suicide rates in 13 of 15 identified studies. While fewer studies were available for other outcomes, lithium was associated with lower rates of homicide, crime, dementia, and mortality. Lead was reported to be ubiquitous in the environment, and chronic low-level exposure has been associated with adverse effects, including effects opposite to the outcomes associated with lithium. Animal studies demonstrated that lithium pre-treatment mitigates lead toxicity. Neurophysiological correlates of lead and lithium exposure overlap.
Microdose lithium is associated with better psychiatric and medical outcomes, which are complementary to harms of environmental lead exposure. Experimental animal evidence is supportive, and lead and lithium impact overlapping neurophysiologic pathways. Therefore, several lines of circumstantial evidence suggest that lithium protects against the neurotoxic effects of lead. Further studies are required to clarify the benefits and mechanisms of low-dose lithium. There are significant public health implications if this paper's hypothesis is true.
锂是一种用于治疗双相情感障碍的药物,也可能预防认知能力下降和自杀。锂在全世界的饮用水中也以低于临床剂量的水平自然存在,且其水平与精神疾病的发病率呈负相关。铅(Pb)是环境中的另一种元素,但也是公共卫生关注的毒素。慢性铅暴露的负面影响和环境锂暴露的可能益处似乎是互补的。
暴露于环境中的锂具有相关益处,这可能是由于锂减轻了铅的毒性。
一系列综述检验了该假说的各个要素。一项系统综述阐明了饮用水中锂的精神和医学相关性。非系统性综述阐明了环境铅的危害,总结了用于预防铅毒性的锂的实验研究,并探讨了锂和铅暴露的重叠生物学机制。
在 15 项已确定的研究中,有 13 项研究表明饮用水中锂含量较高与自杀率较低相关。虽然对于其他结果的研究较少,但锂与较低的凶杀率、犯罪率、痴呆症和死亡率相关。据报道,铅在环境中无处不在,慢性低水平暴露与不良影响有关,包括与与锂相关的结果相反的影响。动物研究表明,锂预处理可减轻铅毒性。铅和锂暴露的神经生理学相关性重叠。
微剂量锂与更好的精神和医学结果相关,这与环境铅暴露的危害互补。实验动物证据是支持的,铅和锂影响重叠的神经生理途径。因此,有几条间接证据表明锂可防止铅的神经毒性作用。需要进一步研究以阐明低剂量锂的益处和机制。如果本文的假设成立,将会产生重大的公共卫生影响。